Robin L. Smith

Insider Reports History

Location
Melville, NY
Signature
/s/ Keith A. Kucinski, attorney-in fact for Robin Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robin L. Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sorrento Therapeutics, Inc. Director Common Stock 235,000 $188,635 $0.8027 03 Sep 2021 Direct
Celularity Inc Director Class A Common Stock 236,066 $58,780 $0.2490 14 Jun 2023 Direct
Celularity Inc Director Stock Option (Right to Buy) 277,778 14 Jun 2023 Direct
Matinas BioPharma Holdings, Inc. Director Stock Option (right to Buy) 11,600 30 Apr 2025 Direct
Sorrento Therapeutics, Inc. Director Stock Options 0 03 Sep 2021 Direct

Insider Reports Filed by Robin L. Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MTNB Matinas BioPharma Holdings, Inc. 30 Apr 2025 1 $0 4 Director 02 May 2025, 17:19
MTNB Matinas BioPharma Holdings, Inc. 13 Feb 2025 0 $0 3 Director 13 Feb 2025, 18:00
CELU Celularity Inc 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 21:02
CELU Celularity Inc 16 Aug 2022 2 $0 4 Director 18 Aug 2022, 18:43
CELU Celularity Inc 13 Jul 2022 2 $0 4 Director 15 Jul 2022, 20:24
WAVS Western Acquisition Ventures Corp. 11 Jan 2022 0 $0 3 Director 11 Jan 2022, 16:36
CELU Celularity Inc 09 Sep 2021 1 $0 4 Director 13 Sep 2021, 18:17
SRNEQ Sorrento Therapeutics, Inc. 03 Sep 2021 4 +$785,250 4 Director 03 Sep 2021, 17:36
SRNEQ Sorrento Therapeutics, Inc. 30 Aug 2021 1 $0 4 Director 30 Aug 2021, 20:15
CELU Celularity Inc 16 Jul 2021 2 $0 4 Director 20 Jul 2021, 21:17
CELU GX Acquisition Corp. 16 Jul 2021 0 $0 3 Director 16 Jul 2021, 17:53